Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ARIAD Pharmaceuticals
Biotech
Theseus clears $100M in series B with Ariad alum at helm
Theseus Pharmaceuticals, led by a team of ex-Ariad executives, will target treatment-resistant cancers after a $100 million series B funding round.
Annalee Armstrong
Apr 13, 2021 11:00am
Chutes & Ladders—Novartis lures UCSF cardiovascular scientist
Aug 18, 2017 7:00am
Chutes & Ladders—Perrigo CEO Hendrickson will retire
Jun 9, 2017 9:00am
Merrimack poaches Ariad CMO after shake-ups for both companies
Jun 8, 2017 9:14am
Ariad finishes rolling NDA for lung cancer; wants sped-up review
Aug 30, 2016 8:53am
